MedPath

Lexent Bio, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"

Terminated
Conditions
Neoplasms, Non-hematologic - Stage I-III
First Posted Date
2017-03-07
Last Posted Date
2019-08-14
Lead Sponsor
Lexent Bio, Inc.
Target Recruit Count
5
Registration Number
NCT03071809
Locations
🇺🇸

Alisa Williams, MD Inc, San Diego, California, United States

Detection of Tumor DNA in Blood Samples From Cancer Patients

Conditions
Cancer
Tumors
First Posted Date
2014-11-11
Last Posted Date
2019-08-14
Lead Sponsor
Lexent Bio, Inc.
Target Recruit Count
500
Registration Number
NCT02288754
Locations
🇺🇸

Cancer Care Associates, Torrance, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.